Alopecia Treatment (Hair Loss) Market Share

Statistics for the 2023 & 2024 Alopecia Treatment (Hair Loss) market share, created by Mordor Intelligence™ Industry Reports. Alopecia Treatment (Hair Loss) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Immune System Drugs Research Autoimmune Disorders Research Androgenetic Alopecia Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Alopecia Treatment (Hair Loss) Industry

Some of the prominent industry players operating in total Alopecia Treatment (Hair Loss) market include Sun Pharmaceuticals Industries Ltd., Aclaris Therapeutics Inc., Cipla Inc., Concert Pharmaceuticals Inc., Daiichi Sankyo Inc. The development of advanced products for better outcomes and rigorous marketing is one of the competitive strategies adopted by the market players. In 2018, HCell Inc., a biotechnology company received orphan drug designation (ODD) for its product from the FDA. Furthermore, in 2017, Perrigo Company PLC. Launched over-the-counter Women's Rogaine, which helps to regrow hair on top of the scalp.

Alopecia Treatment (Hair Loss) Market Leaders

  1. Sun Pharmaceuticals Industries Ltd.

  2. Johnson & Johnson

  3. Concert Pharmaceuticals Inc.

  4. Cipla Inc.

  5. Daiichi Sankyo

*Disclaimer: Major Players sorted in no particular order

Alopecia Treatment (Hair Loss) Market Concentration

Alopecia Treatment (Hair Loss) Market Report Snapshots

Alopecia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)